Thursday, May 29, 2014
109 E 42nd Street
New York, NY 10017
Below is a partial list of the companies that will be presenting.
Acme United Corporation (ACU)
Acme United Corporation is a leading worldwide supplier of innovative branded cutting, measuring and safety products in the school, home, office, hardware & industrial markets. Principal products are scissors, shears, rulers, pencil sharpeners, knives, first aid kits and related products. The company has facilities in the United States, Canada, Germany, Hong Kong and China.
Acme United products are organized under five global brands: Westcott, Clauss, Camillus, Pac Kit and PhysiciansCare, all of which serve a growing customer base that includes the world's premier retailers and merchandisers.
Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis' immunotherapies are based on a novel platform technology using live, attenuated bacteria to stimulate the immune system to selectively target cancer cells while reducing tumor defenses.
AUXILIO is the leading provider of Managed Print Services for Healthcare. A true Management Services company, our focus is to provide turnkey managed print services to our Healthcare clients through situational analysis, strategy development and implementation. We help health systems streamline and align processes and infrastructure to create manageable, dependable print management programs that reduce cost, increase employee productivity and meet and exceed our customers’ patient care standards.
Founded in 2004, AUXILIO serves a national portfolio over 100 health care facilities and manages over 1.6 billion documents annually from over 50,000 devices supporting over 250,000 caregivers. Our business model is vendor neutral and provides full-time, on-site customer service and technical experts at all locations.
Calpian, Inc through its subsidiaries, provides an integrated suite of payment processing services and related software enabling products to the U.S. merchant community. It offers credit and debit card processing, ACH, mobile acceptance, and gateway payment solutions to merchants in the U.S. operating in a physical business environment and/or over the Internet, and in settings requiring wired as well as wireless/portable payment solutions.
Calpian subsidiary Money-on-Mobile, a pre-paid mobile payment solutions platform serves approximately 175,000 retail locations in India and has been utilized by over 82 million unique customers. Calpian, Inc. was incorporated in 2006 and is headquartered in Dallas, Texas.
Cardinal Energy Group, Inc. is a U.S producer of oil and natural gas within the United States. The Company is based in Dublin, Ohio. Cardinal focuses on known formations that have significant proven reserves remaining that can be produced economically. Cardinal targets fields with wells that may need remediation due to neglect or undercapitalization. We select prospects that offer a strong up-side for production. The upside we seek in a prospect is twofold – it must have the potential to be restarted or have its current production increased using newer technology and remediation methods and; it must also have additional lease acreage which can be further developed by completing development wells adjacent to existing producing wells. Cardinal exploits these undervalued assets by acquiring a majority working interest in the prospect and then applies the Company’s calculated development plan. Cardinal also seeks acquisitions of over-leveraged companies when there is a clear upside from their purchase based on strong commodity prices. The Company operates throughout the Continental United States.
CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.
Customers Bancorp, Inc. is the parent holding company of Customers Bank a community-based, full-service bank headquartered in Phoenixville, Pa., with assets of approximately $4.2 billion. A member of the Federal Reserve System with deposits insured by the Federal Deposit Insurance Corporation ("FDIC"), Customers Bank is an equal housing lender that provides a full range of banking services to small and medium-sized businesses, professionals, individuals and families through offices in Pennsylvania, New York, Rhode Island, Massachusetts and New Jersey. Committed to fostering customer loyalty, Customers Bank uses a High Tech/High Touch strategy that includes use of industry-leading technology to provide customers better access to their money, as well as a continually expanding portfolio of loans to small businesses, multi-family projects, mortgage companies and consumers.
DecisionPoint Systems, Inc. delivers improved productivity and operational advantages to its clients by helping them move their business decision points closer to their customers. They do this by making enterprise software applications accessible to the front-line worker anytime, anywhere. DecisionPoint utilizes all the latest wireless, mobility, and RFID technologies.
DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action.
Digital Cinema Destinations Corp. is dedicated to transforming its movie theaters into interactive entertainment centers. The Company provides consumers with uniquely satisfying experiences, combining state-of-the-art digital technology with engaging, dynamic content that far transcends traditional cinematic fare. The Company's customers enjoy live and pre-recorded alternative programming such as concerts, operas, ballets, sporting events, conferences, interactive videogames, auctions, fashion shows and, on an ongoing basis, the very best major motion pictures. As of April 1, 2013, Digiplex operates 18 cinemas and 178 screens in AZ, CA, CT, NJ, OH and PA. You can connect with Digiplex via Facebook, Twitter, YouTube and Blogger. Digiplex is also participating in DigiNext, a unique, specialty content joint venture (with Nehst Studios) featuring curated content from festivals around the world. DigiNext releases typically include innovative live Q&A sessions between the audience and cast members.
DSS, a leader in anti-counterfeit, authentication, and mass-serialization technologies, provides turnkey security solutions to corporations, governments, and financial institutions around the world. Our custom security programs are designed to protect against product diversion, counterfeit, theft, and other costly and damaging occurrences. From risk analysis and vulnerability assessment, to systems integration and monitoring, DSS offers the advanced tools and knowledge base needed to protect the world's most valuable and at-risk brands.
Energous is dedicated to developing wireless energy routers for electronic devices such as cell phones, tablets, cameras, lighting, remote controls, games, toys and more. We have developed a wireless power solution that allows a person to roam while charging. The solution is comprised of a transmitter and receiver(s). Unlike inductive pad technologies, our wireless charging allows you the freedom to roam with your devices while they are charged in an energy pocket which moves and tracks with your device.
Full Circle Capital Corporation is a Rye Brook, New York based closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. Full Circle Capital lends to and invests in senior secured loans and, to a lesser extent, mezzanine loans and equity securities issued by lower middle-market companies that operate in a diverse range of industries. Full Circle Capital’s investment objective is to generate both current income and capital appreciation through debt and equity investments.
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD), an established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences has sold thousands of units, deployed to over 50 countries worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/borders, and emergency response. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, inCal™ automatic internal calibration, rapid clear-down, push button maintenance and no radioactive materials, the Company’s handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection.
Keating Capital is a closed-end fund (regulated as a business development company under the Investment Company Act of 1940) that specializes in making pre-IPO investments in emerging growth companies that are committed to and capable of becoming public. Keating Capital provides investors with the ability to participate in a publicly traded fund that allows its stockholders to share in the potential value accretion that Keating Capital believes typically occurs once a company transforms from private to public status.
Max Sound is the creator of the audio process that brings high definition (HD) sound to digital media. MAX-D is to audio what HD is to video. MAX-D is the technology that dramatically improves sound quality by restoring the lost, compressed sound harmonics, while preserving the smallest possible file size. MAX-D HD is hardware/platform agnostic no need to change equipment or infrastructure. With 23 patents pending, MAX-D makes any system sound better. The first two vertical markets being addressed with the Company's three-pronged "Go To Market" strategy are Music and Mobile. Recent milestones include (a) Qualcomm partnership to develop MAX-D HD on the Snapdragon smartphone chip; (b) completed acquisition of Liquid Spins and subsequent partnership with InComm (billion dollar industry leader of prepaid cards) for prepaid music gift cards and white label program for retailers, (c) signed internationally popular music artist Pitbull as brand ambassador.
NanoViricides, Inc., in a pre-clinical biotech company developing anti-viral drugs to destroy a wide range of viruses in and on the body as well as in the eye. The Company has developed a platform technology, based on the principles of nanotechnology, that enables rapid drug development either in the lab or in the field.
The Company has successfully treated 5000 animals after infection with a wide range of viral diseases. These include all forms of influenza, HIV/AIDS, herpes of the genitals and the eye, adenovirus of the eye, dengue and dengue hemorrhagic fever, rabies and Ebola.
Construction of a new facility and pilot production plant is currently underway and human trials for our influenza cure are now planned for the second half of 2014.
The Company is well funded and currently actively trades on the OTCBB with a market cap of $120M.
NeoStem, Inc. is a leader in the emerging cellular therapy industry. The Company’s business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.
Established in 1999, NetDimensions (AIM: NETD; OTCQX: NETDY) is a global provider of performance, knowledge, and learning solutions. NetDimensions provides companies, government agencies and other organizations with talent management solutions to personalize learning, share knowledge, enhance performance, foster collaboration, and manage compliance programs for employees, customers, partners and suppliers. Recognized as one of the talent management industry's top-rated technology suppliers in overall customer satisfaction, NetDimensions has been chosen by leading organizations worldwide including ING, Cathay Pacific, Hunter Douglas, Chicago Police Department, Geely Automotive, Fugro Group, and Fresenius Medical Care. NetDimensions is ISO 9001 certified and NetDimensions hosted services are ISO 27001 certified.
OncoSec Medical Incorporated is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy therapy to treat solid tumor cancers. OncoSec’s treatment aims to harness the body’s immune system to target and kill cancer cells and consists of using its proprietary electroporation platform to enhance the uptake of a locally delivered DNA-based immunocytokine.
RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally.
Rocky Mountain Chocolate Factory, Inc. (RMCF) incorporated in 1982 and is headquartered in Durango, Colorado. The Company is an international franchisor of gourmet chocolate and confection stores and manufacturer of an extensive line of premium chocolates and other confectionery products. The Company's revenues are derived from three principal sources: sales to franchisees and others of chocolates and other confectionery products manufactured by the Company; the collection of initial franchise fees and royalties from franchisees' sales; and sales at Company-owned stores of chocolates and other confectionery products.
The Company’s majority-owned subsidiary, U-Swirl, Inc. (SWRL), is a franchisor and operator of self-serve frozen yogurt stores. The Company, its subsidiary and its franchisees operates approximately 425 Rocky Mountain Chocolate Factory and U-Swirl self-serve frozen yogurt stores in 42 states, Canada, Japan and the United Arab Emirates.
Soligenix, Inc. is a clinical stage biopharmaceutical company committed to developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD), and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.
Sono-Tek Corporation offers a broad portfolio of ultrasonic atomization-based spray coating products for the Electronics, Advanced Energy, Medical Device, Glass, Textile, and Food Industries. Sono-Tek has two primary operating units (SBUs): Electronics & Advanced Energy (EAE) and Ultrasonic Coating Solutions (UCS):
Electronics & Advanced Energy (EAE)
The EAE strategic business unit saw a decrease of 20% in sales in FY2013 compared to FY2012, mainly due to a decrease in government spending for advanced energy research. It provided spray fluxers for manufacture of printed circuit boards, and special ultrasonic spray coaters for the manufacture of semiconductors (MEMs), PV and thin film solar cells, Fuel Cells, touch screen displays and OLEDs.
Ultrasonic Coating Solutions (UCS)
The UCS business unit saw a decrease of 21% in sales FY2013 compared to FY2012. It provided ultrasonic spray coating systems to the medical device industry (stents, bandages, implantables, and diagnostic devices), as well as WideTrack coaters for the manufacture of float glass, and for spray coating of textiles with functional chemicals such as flame retardants, moisture repellents, and anti-bacterial agents. UCS provided the food industry with equipment for direct food contact coating of flavorings, anti-microbial agents, oils, and moisture barrier compounds.
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX-V: KLH) is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new immunotherapies, and as an injectable product to assess immune response. We are committed to applying our Stellar KLH™ platform to power the growing field of disease-targeting immune therapies.
Straight Path Communications Inc. (NYSE MKT: STRP) is the largest holder of 39 GHz spectrum in the United States through its Straight Path Spectrum subsidiary. Straight Path holds nearly 70% of FCC licensed 39 GHz spectrum, covering all 50 states with exceptionally deep coverage in the top 80 metros. Straight Path leases its 39 GHz spectrum as a high quality alternative to running fiber for telco networks and last mile enterprise applications. Straight Path's 39 Spectrum provides an excellent solution for mobile network operators for nationwide small cell deployment in cities.
The Company's Straight Path IP Group subsidiary holds and licenses its intellectual property for efficient communications over the Internet.
Sutor is one of the leading China-based manufacturers and distributors of high-end fine finished steel products used by a variety of downstream applications. The Company utilizes a variety of in-house developed processes and technologies to convert steel manufactured by third parties into fine finished steel products, including hot-dip galvanized steel, pre-painted galvanized steel, acid-pickled steel, cold-rolled steel and welded steel pipe products.
Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.
Targeted Medical Pharma is a Los Angeles-based biotechnology company that develops prescription medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company manufactures 10 proprietary prescription-only medical foods. These prescription medical foods and therapeutic systems are sold to physicians and pharmacies in the United States through the company€s subsidiary, Physician Therapeutics. These proprietary medications represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. The company is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.
Torchlight Energy Resources, Inc., based in Plano, Texas, is a high growth oil and gas Exploration and Production (E&P) company with a primary focus on acquisition and development of highly profitable domestic oil fields. The company currently holds interests in Texas, Kansas and Oklahoma where their targets are established plays such as the Eagle Ford, Mississippian and Hunton trends.
Towerstream is a leading 4G and Small Cell Rooftop Tower company. The company owns, operates, and leases Wi-Fi and Small Cell rooftop tower locations to cellular phone operators, tower, Internet and cable companies and hosts a variety of customers on its network. Towerstream was originally founded in 2000 to deliver fixed-wireless high-speed Internet access to businesses and to date offers broadband services in over 12 urban markets including New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area. For more information on Towerstream services, please visit www.towerstream.com and/or follow us @Towerstream on Twitter. In 2013, Towerstream Corporation, formed HetNets Tower Corporation (“HetNets”), a wholly owned subsidiary, to offer a neutral host network solution enabling wireless carriers, cable and Internet companies to expand their network footprint and increase coverage and capacity to their platforms.
We design, market, and distribute electronic cigarettes, vaporizers, e-liquids and accessories under the Krave®, Fifty-One® (also known as Smoke 51), VaporX®, Hookah Stix®, Alternacig®, EZ Smoker®, Green Puffer®, Americig®, Fumaré™ and Smoke Star® brands. We also design and develop private label brands for our distribution customers. Our products are manufactured to meet our design specifications. We market our electronic cigarettes as an alternative to traditional tobacco cigarettes. “Electronic cigarettes” or “e-cigarettes,” look like traditional cigarettes and are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide. Our shares of common stock are currently quoted on the OTC Bulletin Board under the symbol VPCO.OB.